Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons
Saved in:
| Published in: | ImmunoTargets and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030190972174337 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | ImmunoTargets and Therapy |
| description | |
| discipline_display | Medical & Health Sciences |
| discipline_facet | Medical & Health Sciences |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:35750 |
| institution | FRELIP |
| journal_source_facet | ImmunoTargets and Therapy |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons — — — — — Allergology and Immunology Clinical Medicine Medical & Health Sciences |
| sub_discipline_display | Clinical Medicine |
| sub_discipline_facet | Clinical Medicine |
| subject_display | — — — — — Allergology and Immunology Clinical Medicine Medical & Health Sciences — — — — — Allergology and Immunology Clinical Medicine Medical & Health Sciences |
| subject_facet | — — — — — Allergology and Immunology Clinical Medicine Medical & Health Sciences |
| title | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_auth | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_full | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_fullStr | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_full_unstemmed | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_short | The Comparative Effectiveness of Enlonstobart and Camrelizumab as Second-Line Recurrent or Metastatic Cervical Cancer Therapies: Matching-Adjusted and Simulated Treatment Comparisons |
| title_sort | the comparative effectiveness of enlonstobart and camrelizumab as second-line recurrent or metastatic cervical cancer therapies: matching-adjusted and simulated treatment comparisons |
| topic | — — — — — Allergology and Immunology Clinical Medicine Medical & Health Sciences |
| url | https://www.dovepress.com/the-comparative-effectiveness-of-enlonstobart-and-camrelizumab-as-seco-peer-reviewed-fulltext-article-ITT |